There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Show figures in :Show figures in :
Data is unavailable
Data is unavailable
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net worth | 2128.35 | 975.14 | 888.09 | 878.57 | 862.95 | 794.39 | 719.53 | 366.71 | 321.43 | 274.24 |
| Fixed assets | 1488.21 | 1179.84 | 1036.92 | 972.05 | 753.42 | 640.82 | 373.45 | 306.74 | 272.09 | 202.62 |
| Debt | 128.64 | 710.16 | 699.23 | 751.32 | 636.70 | 303.68 | 250.10 | 235.34 | 208.44 | 155.04 |
View detailed balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2014 | FY2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 314.05 | 263.09 | 219.40 | 104.87 | -36.38 | 115.50 | 129.14 | 48.97 | 18.53 | 30.19 | 6.92 | 5.26 |
| Investing | -536.67 | -192.38 | -101.78 | -103.71 | -259.89 | -261.69 | -157.66 | -62.20 | -68.69 | -29.62 | -12.26 | -33.31 |
| Financing | 301.43 | -95.30 | -200.65 | 71.92 | 295.50 | -4.07 | 267.53 | 12.45 | 44.15 | 14.86 | 9.15 | 31.11 |
Sai Life Sciences is an integrated CRDMO offering discovery, development, and commercial manufacturing services for small molecules. It partners with global pharmaceutical and biotechnology innovators to accelerate lab-to-market programs.
The company was listed on NSE and BSE on December 18, 2024. The IPO was oversubscribed 10.27 times and resulted in a premium listing on both exchanges
Approximately 97% of revenue is generated from North America, Europe, Japan, and the UK, supported by laboratory presence in the US and UK and manufacturing in India.
